HomeCompareBKGMD vs MRK

BKGMD vs MRK: Dividend Comparison 2026

BKGMD yields 350.88% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKGMD wins by $110.7K in total portfolio value
10 years
BKGMD
BKGMD
● Live price
350.88%
Share price
$14.25
Annual div
$50.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.5K
Annual income
$291.21
Full BKGMD calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BKGMD vs MRK

📍 BKGMD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKGMDMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKGMD + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKGMD pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKGMD
Annual income on $10K today (after 15% tax)
$29,824.56/yr
After 10yr DRIP, annual income (after tax)
$247.53/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,080.88/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKGMD + MRK for your $10,000?

BKGMD: 50%MRK: 50%
100% MRK50/50100% BKGMD
Portfolio after 10yr
$112.1K
Annual income
$5,044.68/yr
Blended yield
4.50%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BKGMD
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKGMD buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKGMDMRK
Forward yield350.88%2.76%
Annual dividend / share$50.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$167.5K$56.8K
Annual income after 10y$291.21$9,798.13
Total dividends collected$91.8K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BKGMD vs MRK ($10,000, DRIP)

YearBKGMD PortfolioBKGMD Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$28,244$17,543.86$11,206$366.19+$17.0KBKGMD
2$53,375$23,154.50$12,650$502.35+$40.7KBKGMD
3$77,559$20,447.44$14,407$694.19+$63.2KBKGMD
4$96,872$13,884.07$16,585$967.82+$80.3KBKGMD
5$111,757$8,103.45$19,342$1,363.89+$92.4KBKGMD
6$123,948$4,368.48$22,913$1,947.19+$101.0KBKGMD
7$134,889$2,264.04$27,662$2,823.89+$107.2KBKGMD
8$145,482$1,151.34$34,159$4,173.35+$111.3KBKGMD
9$156,246$580.26$43,337$6,308.80+$112.9KBKGMD
10$167,475$291.21$56,776$9,798.13+$110.7KBKGMD

BKGMD vs MRK: Complete Analysis 2026

BKGMDStock

BankGuam Holding Company operates as the bank holding company for the Bank of Guam that provides various banking products and services to individuals, businesses, and government entities. It accepts various deposit products, including demand deposits, savings and time certificate of deposits, checking accounts, interest-bearing transaction accounts, time deposits, and retirement accounts for retail and business banking markets. The company also offers commercial loans, which comprise loans to governments primarily in commercial real estate, multifamily rentals, hotel, and gas stations, as well as in working capital and equipment financing; industrial, commercial, real estate, construction, and small business administration-guaranteed loans; home mortgage and home equity loans; and consumer loans for financing automobiles, various consumer goods, and other personal purposes. In addition, it provides trade financing and trust services; and credit life, health, auto, and homeowners insurance services as agents for various insurance companies. Further, the company offers wire and automated clearing house transfers, cashier's and traveler's checks, corporate and consumer credit cards, bank-by-mail, ATMs, night depositories, safe deposit boxes, direct deposits, electronic funds transfers, online banking and bill payments, merchant, check imaging, and other customary banking services. It operates a network of 17 full service branches, including 7 in Guam; one in Saipan and one each in Tinian and Rota, which are located in the Commonwealth of the Northern Mariana Islands; one in the Republic of Palau; one each in the states of Yap, Chuuk, Pohnpei, and Kosrae in the Federated States of Micronesia; one in the Republic of the Marshall Islands; and one in San Francisco, California. The company also operates ATMs at seventy-nine locations. BankGuam Holding Company was incorporated in 1972 and is headquartered in Hagåtña, Guam..

Full BKGMD Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BKGMD vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKGMD vs SCHDBKGMD vs JEPIBKGMD vs OBKGMD vs KOBKGMD vs MAINBKGMD vs JNJBKGMD vs ABBVBKGMD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.